Attached files

file filename
EX-10.5 - Balincan USA, Inc.v179370_ex10-5.htm
EX-10.2 - Balincan USA, Inc.v179370_ex10-2.htm
EX-10.4 - Balincan USA, Inc.v179370_ex10-4.htm
EX-10.1 - Balincan USA, Inc.v179370_ex10-1.htm
EX-10.3 - Balincan USA, Inc.v179370_ex10-3.htm
 

 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): March 29, 2010

 
MOQIZONE HOLDING CORPORATION
(Exact name of registrant as specified in Charter)

Delaware
0-23000
95-4217605
(State or other jurisdiction of
incorporation or
organization)
(Commission File No.)
(IRS Employee
Identification No.)

7A-D Hong Kong Industrial Building, 444-452 Des Voeux Road West, Hong Kong
 (Address of principal executive offices)

Registrant’s telephone number, including area code:
(949) 903-0468
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

Item 1.01                      Entry into a Material Definitive Agreement.
Item 3.02                      Unregistered Sales of Equity Securities.
Item 9.01                      Financial Statements and Exhibits.
 
We completed a private equity financing of $1,956,000 on March 29, 2010, with 7 accredited investors.  Net proceeds from the offering, are approximately $1,760,400.  Pursuant to the financing, we issued, for $1,956,000, a total of 869,333 units of our securities at $2.25 per unit.  Each Unit consists of (i) one (1) share of the Company’s  Series C Convertible Preferred Stock, par value $0.001 per share (the “Preferred Shares”), convertible into one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) a Series C Warrant (the “Series C Warrant”) and Series D Warrant (the “Series D Warrant”), collectively the “Warrants”), with the total amount of Warrants of each Series exercisable to purchase that number of shares of Common Stock as shall be equal to fifty percent (50%) of the number of Units purchased in the Offering.  Each of the Warrants has a term of three (3) years.

In connection with this financing, we paid cash compensation to a placement agent in the amount of $195,600.00.  Additionally, in connection with this financing, we granted warrants to purchase up to 86,933 shares of common stock, Series C Warrants to purchase up to 43,467 shares of common stock and Series D Warrants to purchase 43,467 shares of common stock to the placement agent or its designees.  These warrants have the same terms as the warrants issued to Investors that are included in the Units.
 
In connection with the Financing, we also entered into a Registration Rights Agreement with the Investors (the “Investor RRA”).  Under the Investor RRA, the Company is required to prepare and file a registration statement for the resale of the Common Stock and the Common Stock underlying the Warrants and to use its best efforts to cause, and to maintain, the effectiveness of the registration statement.  The Company is subject to certain monetary obligations if, among other reasons, the Company fails to file the registration statement with the SEC within 45 days of the date of the Registration Rights Agreement or the registration statement is not declared effective by the SEC within 150 days (180 days if the registration statement gets reviewed by the SEC) from the date of the Registration Rights Agreement.  The obligations are payments in an amount equal to 2% of the aggregate amount invested by such Investor (based upon the number of Registrable Securities then owned by such Investor) for each 30 day period or any portion thereof following the date by which such Registration Statement should have been effective, up to a maximum amount of 10%.  Furthermore, in the event that the Registration Statement is not effective in the timeframe stated in the RRA, the warrants contain a “cashless” exercise provisions.

The foregoing information has been disclosed herein as it is material to the private equity financing and should not be construed as an offer to sell or solicitation of an offer to buy our securities.  The private equity financing described herein was made pursuant to the exemption from the registration provisions of the Securities Act of 1933, as amended, provided by Sections 3(a)(9) and 4(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder. The securities issued have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 
-1-

 


The foregoing information has been disclosed herein as it is material to the Financings and should not be construed as an offer to sell or solicitation of an offer to buy our securities.

Recent Sales of Unregistered Securities.

Reference is made to the disclosures set forth above. We believe that all of the sales of such unregistered securities were and will be exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(2) of the Securities Act, Rule 506 of Regulation D and/or Regulation S as promulgated by the SEC.

Item 9.01. 
 Financial Statements and Exhibits.
 
 
(a)
Not applicable.

 
(b)
Not applicable.

 
(c)
Exhibits

See the Exhibit Index hereto, which is incorporated by reference herein.

 
-2-

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MOQIZONE HOLDINGS CORP.
(Registrant)
   
By:
 
 
Name:  Lawrence Cheung
 
Title: Chief Executive Officer

Date:  March 30, 2010

 
-3-

 

EXHIBIT INDEX

10.1
Form of Securities Purchase Agreement dated March 29, 2010
   
10.2
Form of Registration Rights Agreement dated March 29, 2010
   
10.3
Form of Series C Certificate of Designation
   
10.4
Form of Series C Warrant
   
10.5
Form of Series D Warrant
 
 
-4-